Showing results (21-30 of 238) with videos related to
Sort By:
Pageof 24
Rheumatology (Oxford, England)|April 5, 2007
Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritisT Sokka, H Mäkinen, P Hannonen, et al.Annals of the Rheumatic Diseases|December 17, 2008
Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trialT Pincus, C J Swearingen, G Luta, et al.Annals of the Rheumatic Diseases|December 13, 2005
Declines in number of tender and swollen joints in patients with rheumatoid arthritis seen in standard care in 1985 versus 2001: possible considerations for revision of inclusion criteria for clinical trialsT Pincus, T Sokka, C P Chung, et al.Annals of the Rheumatic Diseases|June 3, 2006
Work disability in early rheumatoid arthritis: higher rates but better clinical status in Finland compared with the USC P Chung, T Sokka, P G Arbogast, et al.Clinical and Experimental Rheumatology|February 19, 2004
Methotrexate as the "anchor drug" for the treatment of early rheumatoid arthritisT Pincus, Y Yazici, T Sokka, et al.Annals of the Rheumatic Diseases|June 23, 2004
Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalitiesY Yazici, T Sokka, H Kautiainen, et al.Rheumatology (Oxford, England)|December 7, 2002
Evidence from clinical trials and long-term observational studies that disease-modifying anti-rheumatic drugs slow radiographic progression in rheumatoid arthritis: updating a 1983 reviewT Pincus, G Ferraccioli, T Sokka, et al.Clinical and Experimental Rheumatology|February 19, 2004
Early rheumatoid arthritis in FinlandT SokkaClinical and Experimental Rheumatology|November 4, 2010
Increases in use of methotrexate since the 1980sT SokkaClinical and Experimental Rheumatology|February 19, 2004
Work disability in early rheumatoid arthritisT SokkaPageof 24